INDUSTRY UPDATES
September 13, 2019
Contact your Member of Congress to urge the FDA to take action on CBD
As you are well aware, the primary policy challenge facing the hemp-derived CBD industry is guidance issued by FDA, opining that it is illegal for CBD to be introduced into interstate commerce as a food additive or dietary supplement. While the FDA has announced that it will unveil its timetable for action this fall, it could be many months before they issue a formal regulation.
Two of our hemp champions in Congress, Reps. Chellie Pingree (D-ME) and James Comer (R-KY) have joined forces to do something about it. And they need your help to rally other Congressmen to join the fight.
Yesterday, Reps. Pingree and Comer sent all members of the US House of Representatives a “Dear Colleague” letter, asking them to co-sign a letter that urges the FDA to issue formal “enforcement discretion” on the sale of hemp CBD products. This would mean that the FDA would formally stand down on any enforcement of its troublesome anti-CBD guidance. Such a policy would remove significant risk from the sale of CBD products.
Please email your Member of Congress TODAY, urging him or her to co-sign the Pingree/Comer FDA letter.
As always, we have made it super easy for you to contact your Representative. Simply click onto our online portal, with your email and zip code, and a message will automatically populate to be sent to your Congressman. Please feel free to personalize the message to explain why hemp CBD is important to you, your family, your company, or your farm.
